<DOC>
	<DOCNO>NCT01759966</DOCNO>
	<brief_summary>The purpose prospective study investigate denervation ( ie . surgical cut autonomic nerve ) re-innervation ( ie . growth autonomic nerve ) heart transplant recipient . More specifically , focus : 1 . The physiological consequence denervation , particular consequence clinical symptom , orthostatic tolerance ( ie . ability stand upright ) exercise capacity . We hypothesize denervation negative consequence factor . 2 . The pathological consequence denervation reinnervation , particular association acute rejection coronary artery disease ( cardiac allograft vasculopathy , CAV ) . We hypothesize reinnervation protects acute rejection development CAV 3 . Donor recipient factor associate reinnervation process . We hypothesize characteristic surgical procedure ( aorta cross-clamp time ) well rehabilitation process recipient ( physical activity ) impact reinnervation process .</brief_summary>
	<brief_title>Autonomic Cardiovascular Control After Heart Transplantation</brief_title>
	<detailed_description>Heart transplantation annually offered 3500 patient worldwide . In Norway , number approximately 30/year , transplant carry one single hospital ( Oslo University Hospital , Rikshospitalet ) . Normally , heart function intimately control autonomic nervous system ( ANS ) , nervous connection lose surgical transplantation procedure , transplant heart thus becomes denervated . In time , regrowth nerve may cause partial reinnervation new heart . Some evidence suggest reinnervation improves exercise capacity reduces episodes acute rejection development cardiac allograft vasculopathy . The purpose study investigate change time respect part autonomic nervous system ( sympathetic , parasympathetic sensoric part ) , associate physiological pathological consequence . The study may provide knowledge ultimately could help u improve health quality live heart transplant recipient .</detailed_description>
	<criteria>Inclusion Criteria HTRs : Completed heart transplantation last 712 week Age &gt; 16 year &lt; 70 year Exclusion criterion HTRs : Peri postoperative complication cause permanent dysfunction allograft ( hyperacute rejection episode , severe myocardial ischemia , etc . ) Diabetes HbA1C &gt; 6,5 % and/or manifest diabetic complication Renal failure plasma creatinine &gt; 200 Âµmol/L ECG abnormality ( scattered ectopic beat ad minor conduction problem allow ) Permanently bedridden Inclusion criterion healthy control : Age gender match HTRs Exclusion criterion healthy control : Another chronic disease ( diabetes mellitus ) Permanent use pharmaceutical ( include hormone drug ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Heart transplantation</keyword>
	<keyword>Autonomic cardiovascular control</keyword>
	<keyword>Acute rejection</keyword>
	<keyword>Cardiac allograft vasculopathy</keyword>
</DOC>